Israel Englander Merck & Co., Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,060,700 shares of MRK stock, worth $139 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,060,700

Previous 6,047,952 82.46%

Holding current value

$139 Million

Previous $659 Million 78.77%

% of portfolio

0.06%

Previous 0.29%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $455 Million - $531 Million	4,021,500 Added 66.49%	10,069,452 $1.33 Billion
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $601 Million - $654 Million	6,000,091 Added 12536.49%	6,047,952 $659 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $1.13 Million - $1.23 Million	10,410 Added 27.8%	47,861 $5.52 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $144 Million - $161 Million	-1,400,471 Reduced 97.4%	37,451 $3.98 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $8.27 Million - $10.6 Million	94,582 Added 7.04%	1,437,922 $160 Million

Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $138 Million - $155 Million	-1,634,914 Reduced 54.9%	1,343,340 $116 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $12.2 Million - $13.8 Million	146,148 Added 5.16%	2,978,254 $272 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $131 Million - $147 Million	1,783,607 Added 170.11%	2,832,106 $232 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $4.64 Million - $5.81 Million	64,223 Added 6.52%	1,048,499 $80.4 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $36.9 Million - $40.6 Million	514,993 Added 109.74%	984,276 $73.9 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $39.3 Million - $43.4 Million	-558,319 Reduced 54.33%	469,283 $36.5 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $20 Million - $23.6 Million	290,407 Added 39.39%	1,027,602 $79.2 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $5.99 Million - $6.65 Million	83,510 Added 12.78%	737,195 $60.3 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $27.5 Million - $31.2 Million	376,326 Added 135.68%	653,685 $54.2 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $98.1 Million - $112 Million	-1,392,419 Reduced 83.39%	277,359 $21.4 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $15.6 Million - $21.6 Million	245,885 Added 17.27%	1,669,778 $128 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $106 Million - $119 Million	1,363,355 Added 2252.06%	1,423,893 $130 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $3 Million - $3.27 Million	39,448 Added 187.05%	60,538 $5.1 Million
Q2 2019 Aug 15, 2019	SELL	$69.84 - $81.59 $4.91 Million - $5.74 Million	-70,304 Reduced 76.92%	21,090 $1.77 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $6.38 Million - $7.46 Million	91,394 New	91,394 $3.31 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $341 Million - $389 Million	-4,906,087 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $72.1 Million - $83.6 Million	1,104,867 Added 29.07%	4,906,087 $375 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $66.8 Million - $78.6 Million	1,157,954 Added 43.81%	3,801,220 $270 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $13.6 Million - $16 Million	268,391 Added 11.3%	2,643,266 $160 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $79.1 Million - $91.9 Million	1,552,401 Added 188.75%	2,374,875 $129 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $95.5 Million - $114 Million	-1,849,820 Reduced 69.22%	822,474 $46.3 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $157 Million - $169 Million	2,672,294	2,672,294 $171 Million

Others Institutions Holding MRK

# of Institutions

3,757

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $332B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account